1. | answerboy79 | |
2. | wjohenning2756 | |
3. | pita47429 | |
4. | spottedgecko7 | |
5. | mevol77 |
1. | answerboy79 | |
2. | wjohenning2756 | |
3. | pita47429 | |
4. | spottedgecko7 | |
5. | mevol77 |
1. | wjohenning2756 02/21/2018 Announces publication of the results from the Phase 1 |
2. | spottedgecko7 01/08/2018 Facts - TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement for Development and Commercialization of Novel BTK Inhibitor Program for the Treatment of Hematologic Malignancie |
3. | wjohenning2756 06/04/2018 TG Therapeutics, Inc. Announces Umbralisib Clinical Data Presentation at the 54th Annual Meeting of the American Society of Clinical Oncology |
4. | answerboy79 02/21/2018 I bought in over a year ago |
5. | mevol77 04/24/2018 TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the American Academy of Neurology 70th Annual Meeting |
6. | mevol77 07/09/2018 Files for 216,294 share common stock offering by selling shareholders |
7. | zbzapp95 02/21/2018 Seems like $20 getting closer every day |
8. | jcherolis 06/04/2018 Top Analyst Weighs in on TG Therapeutics (TGTX) Following Encouraging ASCO Update |
9. | answerboy79 02/21/2018 The bid is strong. Good depth |
10. | spottedgecko7 02/21/2018 watching for more {Image} |